Methimazole disrupted skeletal ossification and muscle fiber transition in Bufo gargarizans larvae
Methimazole (MMI) is an emerging endocrine disrupting chemical (EDC) due to its increasing use in the treatment of thyrotoxicosis (hyperthyroidism), but its potential impact on amphibian development remains largely unexplored. In the present study, the effects of 8 mg/L MMI and 1 μg/L thyroxine (T4)...
Saved in:
Main Authors: | Fei Wei, Xueyi Wu, Hongyuan Wang, Yongpu Zhang, Lei Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Ecotoxicology and Environmental Safety |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S014765132500020X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil
by: Jaeduk Yoshimura Noh, et al.
Published: (2024-07-01) -
Impaired fracture healing is associated with callus chondro-osseous junction abnormalities in periostin-null and osteopontin-null mice
by: Marc Teitelbaum, et al.
Published: (2025-01-01) -
MLL4 regulates postnatal palate growth and midpalatal suture development
by: Jung-Mi Lee, et al.
Published: (2025-01-01) -
<i>Ex Vivo</i> Regional Gene Therapy Compared to Recombinant BMP-2 for the Treatment of Critical-Size Bone Defects: An In Vivo Single-Cell RNA-Sequencing Study
by: Arijita Sarkar, et al.
Published: (2025-01-01) -
The Relationship Between Ossification in Metacarpophalangeal Sesamoids of the Thumb and the Period of Puberty: A Radiographic Study
by: Rifat SAHIN, et al.
Published: (2022-12-01)